Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1896 1
1897 1
1940 1
1946 1
1947 2
1950 1
1951 2
1953 1
1954 4
1955 2
1956 1
1957 2
1958 1
1959 2
1960 1
1961 4
1962 3
1963 4
1964 5
1965 3
1966 2
1967 5
1968 7
1969 7
1970 4
1971 13
1972 10
1973 9
1974 16
1975 27
1976 34
1977 14
1978 14
1979 20
1980 15
1981 22
1982 47
1983 37
1984 37
1985 37
1986 61
1987 43
1988 47
1989 52
1990 70
1991 52
1992 68
1993 49
1994 46
1995 47
1996 54
1997 60
1998 71
1999 81
2000 122
2001 131
2002 134
2003 158
2004 201
2005 196
2006 207
2007 257
2008 271
2009 291
2010 332
2011 330
2012 417
2013 452
2014 672
2015 721
2016 821
2017 840
2018 995
2019 1221
2020 1413
2021 1555
2022 1778
2023 1481
2024 1356
2025 1384
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,766 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Koranian
Page 1
Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplant-ineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial.
Manier S, Dimopoulos MA, Leleu XP, Moreau P, Cavo M, Goldschmidt H, Orlowski RZ, Tron M, Tekle C, Brégeault MF, Shafer AT, Beksac M, Facon T. Manier S, et al. Haematologica. 2025 Sep 1;110(9):2139-2150. doi: 10.3324/haematol.2024.287200. Epub 2025 Mar 20. Haematologica. 2025. PMID: 40109195 Free PMC article. Clinical Trial.
All patients received standard VRd/Rd dosing; Isa-VRd patients received intravenous Isa (cycle 1, 10 mg/kg once weekly; cycles 2-17, once every 2 weeks; subsequent cycles, once every 4 weeks). ...Using this scoring, 26.7% of patients were frail (26.0% Isa-VRd …
All patients received standard VRd/Rd dosing; Isa-VRd patients received intravenous Isa (cycle 1, 10 mg/kg once weekly; cycles …
Voclosporin.
[No authors listed] [No authors listed] 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 34699156 Free Books & Documents. Review.
ISA 247: trans-ISA 247, trans-R 1524, ISA(TX)247, ISAtx 247, ISATx247, LX 211, LX211, R 1524, R-1524.
[No authors listed] [No authors listed] Drugs R D. 2007;8(2):103-12. doi: 10.2165/00126839-200708020-00005. Drugs R D. 2007. PMID: 17324008 Review.
Under the terms of the agreement, Lonza will manufacture sufficient quantities of trans-ISA 247 in a GMP environment for use in the company's upcoming clinical trials. Isotechnika completed the phase III SPIRIT trial of ISA 247 for psoriasis in Canada. ...Half of th …
Under the terms of the agreement, Lonza will manufacture sufficient quantities of trans-ISA 247 in a GMP environment for use in the c …
Population Pharmacokinetics of Isavuconazole in Adult: A Systematic Review.
Chen N, Wang X, Li Y, Yang P, Huang M, Lu X. Chen N, et al. Infect Drug Resist. 2023 Dec 8;16:7559-7568. doi: 10.2147/IDR.S434622. eCollection 2023. Infect Drug Resist. 2023. PMID: 38089964 Free PMC article. Review.
In recent years, population pharmacokinetic studies of ISA have been reported continuously. This paper aims to summarize the characteristics of population pharmacokinetic models of ISA in adults, and provide theoretical basis for individualized administration of …
In recent years, population pharmacokinetic studies of ISA have been reported continuously. This paper aims to summarize the characte …
Seizure onset determination.
Rodin E, Constantino T, Rampp S, Modur P. Rodin E, et al. J Clin Neurophysiol. 2009 Feb;26(1):1-12. doi: 10.1097/WNP.0b013e3181969017. J Clin Neurophysiol. 2009. PMID: 19151615 Review.
Inasmuch as ISA and HFA have considerably smaller electrical fields than the conventional frequencies they may better define seizure onset than might be possible otherwise. It is recommended that to determine the clinical value of ISA and HFA for epilepsy surgery, r …
Inasmuch as ISA and HFA have considerably smaller electrical fields than the conventional frequencies they may better define seizure …
Isatuximab, carfilzomib and dexamethasone (Isa-Kd) for the management of relapsed multiple myeloma.
Banerjee R, Lo M, Martin TG 3rd. Banerjee R, et al. Future Oncol. 2021 Dec;17(35):4849-4860. doi: 10.2217/fon-2021-0778. Epub 2021 Sep 23. Future Oncol. 2021. PMID: 34553603 Review.
In this review we discuss the rationale and clinical trial experience to date with Isa-Kd. Although final IKEMA results are pending, Isa-Kd has emerged as an effective and tolerable therapy for patients with relapsed multiple myeloma. ...In this review, we discuss p …
In this review we discuss the rationale and clinical trial experience to date with Isa-Kd. Although final IKEMA results are pending, …
Isavuconazole-tacrolimus drug-drug interactions in HSCT patients.
Fructuoso-González L, Najera-Perez MD, Manresa-Ramón N, Torrano-Belmonte P, Caracena-López S, Pacheco-López P. Fructuoso-González L, et al. J Antimicrob Chemother. 2023 Oct 3;78(10):2559-2562. doi: 10.1093/jac/dkad271. J Antimicrob Chemother. 2023. PMID: 37667501
OBJECTIVES: Because tacrolimus has a narrow therapeutic window and exhibits both intraindividual and interindividual variability, we attempted to establish the percentage of calcineurin inhibitor (CNI) dose reduction to prevent toxicity and ensure stem cell engraftment when using …
OBJECTIVES: Because tacrolimus has a narrow therapeutic window and exhibits both intraindividual and interindividual variability, we attempt …
A physiologically based pharmacokinetic analysis to predict the pharmacokinetics of intravenous isavuconazole in patients with or without hepatic impairment.
Huang H, Xie H, Chaphekar N, Xu R, Venkataramanan R, Wu X. Huang H, et al. Antimicrob Agents Chemother. 2023 May 1;65(5):e02032-20. doi: 10.1128/AAC.02032-20. Epub 2021 Feb 22. Antimicrob Agents Chemother. 2023. PMID: 33619060 Free PMC article.
Isavuconazole (ISA) is an azole antifungal used in the treatment of invasive aspergillosis and mucormycosis. Patients with mild and moderate hepatic impairment have lower clearance (CL) as compared to the healthy population. Currently, there is no data on ISA in pat …
Isavuconazole (ISA) is an azole antifungal used in the treatment of invasive aspergillosis and mucormycosis. Patients with mild and m …
Montanide ISA-51: a promising adjuvant in cancer vaccine immunotherapy.
Nan L, Zhang X, Ziyi L, Li S, Xia N. Nan L, et al. Expert Rev Vaccines. 2025 Dec;24(1):958-971. doi: 10.1080/14760584.2025.2576234. Epub 2025 Oct 22. Expert Rev Vaccines. 2025. PMID: 41102132 Free article. Review.
AREAS COVERED: This review examines the current applications of Montanide ISA-51 in cancer vaccines, explores its immunoregulatory mechanisms, highlights the challenges in its use as a vaccine adjuvant, and proposes avenues for future optimization. ...These insights will a …
AREAS COVERED: This review examines the current applications of Montanide ISA-51 in cancer vaccines, explores its immunoregulatory me …
15,766 results
You have reached the last available page of results. Please see the User Guide for more information.